About the ABPI

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

About the PMCPA 

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI.

The PMCPA is a division of the ABPI. The Code covers the promotion of medicines for prescribing to health professionals and the provision of information to the public about prescription only medicines.

If you have any concerns about the activities of pharmaceutical companies in this regard, please contact the PMCPA at 7th Floor, 105 Victoria St, London, SW1E 6QT or mail: complaints@pmcpa.org.uk.

PMCPA Press Office

Elly Button

T: 07920 863650

E: ebutton@pmcpa.org.uk  

The ABPI requests that companies collate all internal comments to provide one overall response per company.

The timescales take account of the need for a period of training and familiarisation with the new layout of the Code.

Further explanation of the changes is on the PMCPA website, and other key elements of the changes are below.

Because of the new layout into six sections, the new version has seen some clauses and supplementary information:

  • split between more than one section
  • duplicated as they are required to be in more than one section
  • or deleted as they are no longer required
  • and some supplementary information has been moved, either to be included in the relevant clause or to Q&A

Changes as a consequence of EFPIA updates include:

  • Adopting or amending definitions, for example on sponsorship, support and events
  • Expanding Donations and Grants to cover patient organisations, and to replace medical educational goods and services (MEGS) in the current ABPI Code
  • Incorporating patient organisations and individuals representing patient organisations into relevant Code activities, namely
    • Donations and Grants
    • Sponsorship of organisations in relation to Events and Meetings and other activities
    • Contracted Services
    • Disclosure, aligning with the timings of other Disclosures.

Other changes include:

  • A new section on collaborative working, to better reflect the activities companies undertake in this area. Collaborative working must enhance patient care or be for the benefit of patients, or alternatively benefit the NHS and as a minimum maintain patient care. This section incorporates the current joint working definition as an example of a type of collaborative working.
  • Including members of the public (such as patients or journalists) in the Contracted Services requirements, where they provide services similar to those already covered in the Code.
  • An additional requirement to disclose payments to members of the public not representing a patient organisation, including patients, journalists etc, from 2022.

Media enquiries

+44 (0) 20 7747 7147​​